Srinivas R. Viswanathan, Ph.D.
Affiliations: | 2009 | Harvard University, Cambridge, MA, United States |
Area:
Molecular Biology, Genetics, Cell BiologyGoogle:
"Srinivas Viswanathan"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| I. George Miller | research assistant | 2001-2004 | Yale (Cell Biology Tree) | |
| George Q. Daley | grad student | 2009 | Harvard | |
| (Lin28: An inhibitor of microRNA biogenesis with roles in cancer and development.) | ||||
| Matthew Meyerson | post-doc | (Neurotree) | ||
Children
Sign in to add trainee| Stephen P Martindale | research assistant | Dana-Farber Cancer Institute and Harvard Medical School (ID Tree) | |
| Ananthan Sadagopan | research assistant | (ID Tree) | |
| Stephen Tang | research assistant | 2019-2020 | Harvard (GenetiTree) |
| Emma Renee Garner | research scientist | 2019- | Dana Farber Cancer Institute, Harvard Medical School (Neurotree) |
| Nebiyou Yonas Metaferia | research scientist | 2019-2021 | Dana Farber Cancer Institute (FlyTree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Achom M, Sadagopan A, Bao C, et al. (2023) A genetic basis for cancer sex differences revealed in Xp11 translocation renal cell carcinoma. Biorxiv : the Preprint Server For Biology |
| Saad E, Saliby RM, Labaki C, et al. (2023) Novel Immune Therapies for Renal Cell Carcinoma: Looking Beyond the Programmed Cell Death Protein 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 Axes. Hematology/Oncology Clinics of North America |
| Sadagopan A, Nasim IT, Li J, et al. (2022) Somatic XIST activation and features of X chromosome inactivation in male human cancers. Cell Systems. 13: 932-944.e5 |
| Konda P, Viswanathan SR. (2022) How splicing confers treatment resistance in prostate cancer. Elife. 11 |
| Zhou M, Ko M, Hoge AC, et al. (2022) Patterns of structural variation define prostate cancer across disease states. Jci Insight |
| Tang S, Sethunath V, Metaferia NY, et al. (2022) A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer. Cell Reports. 38: 110417 |
| Bakouny Z, Sadagopan A, Ravi P, et al. (2022) Integrative clinical and molecular characterization of translocation renal cell carcinoma. Cell Reports. 38: 110190 |
| Alesi N, Akl EW, Khabibullin D, et al. (2021) TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism. Nature Communications. 12: 4245 |
| Bakouny Z, Braun DA, Shukla SA, et al. (2021) Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma. Nature Communications. 12: 808 |
| Pomerantz MM, Qiu X, Zhu Y, et al. (2020) Prostate cancer reactivates developmental epigenomic programs during metastatic progression. Nature Genetics |